M&A Deal Summary |
|
|---|---|
| Date | 2022-04-27 |
| Target | AirTies |
| Sector | Internet Software and Services |
| Buyer(s) | Providence Equity Partners |
| Sellers(s) | The Invus Group |
| Deal Type | Secondary Buyout |
| Advisor(s) | Stifel, Nicolaus & Co., Inc. (Financial) Baker & McKenzie DLA Piper (Legal) |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Private Equity Firm |
|---|---|
| Founded | 1989 |
| PE ASSETS | 36.0B USD |
| Size | Mega |
| Type | Sector Agnostic |
Providence Equity Partners is a specialist private equity firm that targets investments in media, entertainment, communications, and information companies. Specifically, Providence seeks investments in wireless and wireline telephony, cable television content and distribution, music, film, publishing, radio and television broadcasting, and other media and communications sectors. Providence Equity looks to commit $150 million to $800 million of equity capital in transactions ranging from growth financings and recapitalizations, to buyouts and take-privates. Providence Equity Partners was formed in 1989 and has offices in Providence, Rhode Island; New York, New York; Los Angeles, California; London, United Kingdom; Hong Kong, China; and New Delhi, India.
| DEAL STATS | # |
|---|---|
| Overall | 126 of 133 |
| Sector (Internet Software and Services) | 14 of 15 |
| Type (Secondary Buyout) | 32 of 36 |
| Country (France) | 3 of 4 |
| Year (2022) | 1 of 4 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2022-01-01 |
Grupo TorreSur
Sao Paulo, Brazil Grupo TorreSur is a wireless tower company, that provides infrastructure sharing services which consist of a full turn-key tower leasing service, build-to-suit options, collocation platforms and tower space on a shared basis, under long-term leases, to wireless communications service providers. Grupo TorreSur was founded in 2010 and is based in Sao Paulo, Brazil. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2022-06-08 |
Vistage
San Diego, California, United States Vistage is a forum for business leaders to share their issues and experiences to help each other generate better decisions and results for their companies. Vistage members provide each other the same kind of counsel and support by meeting in person, collaborating online, and learning from hundreds of top industry speakers. Vistage was founded in 1957 and is based in San Diego, California. |
Sell | - |
| Category | Private Equity Firm |
|---|---|
| Founded | 1985 |
| PE ASSETS | 8.0B USD |
| Size | Mega |
| Type | Sector Agnostic |
The Invus Group is a private, global investment firm that makes equity investments in private and public companies. For private companies, Invus seeks control as well as minority investments in high-growth companies where the firm can add strategic value. For public companies, Invus looks to invest in small to mid-cap stocks that are trading below the firm's assessment of their intrinsic business value. Areas of interest include consumer products and services, food, specialty retail, software, biotech, medical devices and products and services to professionals. Invus typically targets investments in the US, Europe, and Asia. The Invus Group was formed in 1985 and is based in New York City.
| DEAL STATS | # |
|---|---|
| Overall | 5 of 5 |
| Sector (Internet Software and Services) | 2 of 2 |
| Type (Secondary Buyout) | 1 of 1 |
| Country (France) | 1 of 1 |
| Year (2022) | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-03-01 |
Fog Pharma
Cambridge, Massachusetts, United States FogPharma, a biopharmaceutical company with a mission to drastically reduce the burden of disease on patients and their families by inventing new types of drugs that squelch abnormal physiological processes in ways previously imagined but considered unattainable. The company is pioneering the discovery, development and commercialization of Helicon™ peptides, a new drug modality that uniquely combines the cell-permeability and oral dosing optionality of traditional small molecule drugs with the high specificity, broad target accessibility and rapid discovery arc of monoclonal antibody drugs. Fog Pharma was founded in 2016 and is based in Cambridge, Massachusetts. |
Buy | - |
